top of page

Ready to Plug-in? Elon Musk's Neuralink Looking for a Clinical Trial Partner


Figure 1. Elon Musk's Neuralink accused of unsafely transporting infected material. Retrieved from www.techspot.com


Elon Musk's Neuralink, the brain implant company, is on the hunt for a partner to help with its clinical trials. The company has applied to the FDA for approval to begin human trials and is now in search of a partner to help them make it happen.


The goal of Neuralink is to develop technology that can be used to treat neurological disorders such as Parkinson’s disease, epilepsy, and depression. The device they are developing would be implanted into the brain and use tiny electrodes to monitor and stimulate neural activity.


The potential benefits of this technology are immense. It could allow doctors to monitor patients’ brain activity more closely than ever before, potentially leading to earlier diagnosis and treatment of neurological conditions. It could also enable people with paralysis or other motor impairments to regain control over their movements.


Figure 2. Video Thumbnail for The Science Behind Elon Musk’s Neuralink Brain Chip. Retrieved from www.wired.com


Neuralink has already successfully tested its technology on animals, but it still needs more data before it can move forward with human trials. That’s why they are seeking a partner who can provide access to clinical trial participants and resources needed for testing the device in humans.


If all goes well, we could see Neuralink’s technology being used in humans as soon as 2024. This would be a major breakthrough in medical science, potentially revolutionizing how we treat neurological disorders and helping millions of people around the world live better lives.


Sources:

  • https://www.fiercebiotech.com/medtech/musks-neuralink-seeking-clinical-trial-partner-it-awaits-fda-go-ahead-reuters

  • https://www.reuters.com/business/healthcare-pharmaceuticals/musks-brain-implant-company-search-human-trials-partner

35 views0 comments

Comments


bottom of page